SureTrader Nadex Advertisement Interactive Brokers Advertisement SureTrader
Home > Boards > US Listed > Biotechs > ImmunoCellular Therapeutics, Ltd. (IMUC)

totally agree with that

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
biomanbaba Member Profile
 Grandfathered Member
Followed By 205
Posts 14,251
Boards Moderated 1
Alias Born 02/04/01
160x600 placeholder
Current Report Filing (8-k) "Edgar (US Regulatory)" - 5/16/2017 1:44:35 PM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 5/15/2017 5:52:53 PM
ImmunoCellular Therapeutics Announces First Quarter 2017 Financial Results "PR Newswire (US)" - 5/15/2017 4:06:00 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 5/5/2017 4:07:21 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) "Edgar (US Regulatory)" - 4/28/2017 4:31:58 PM
Proxy Statement (definitive) (def 14a) "Edgar (US Regulatory)" - 4/28/2017 4:24:19 PM
Proxy Soliciting Materials (revised) (prer14a) "Edgar (US Regulatory)" - 4/24/2017 6:09:13 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 4/20/2017 4:18:20 PM
Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) "Edgar (US Regulatory)" - 4/17/2017 4:17:34 PM
Securities Registration Statement (s-1/a) "Edgar (US Regulatory)" - 4/4/2017 6:08:08 AM
ImmunoCellular Therapeutics and Memgen Announce Letter of Intent for Potential Joint Immuno-Oncology Collaboration "PR Newswire (US)" - 3/23/2017 6:00:00 AM
ImmunoCellular Therapeutics Receives Audit Opinion With Going Concern Explanation "PR Newswire (US)" - 3/14/2017 4:05:00 PM
Annual Report (10-k) "Edgar (US Regulatory)" - 3/9/2017 5:14:25 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 3/9/2017 4:18:39 PM
ImmunoCellular Therapeutics Announces Fourth Quarter and Full Year 2016 Financial Results and Provides Corporate Update "PR Newswire (US)" - 3/9/2017 4:05:00 PM
ImmunoCellular Therapeutics to Report Fourth Quarter and Full Year 2016 Financial Results on March 9, 2017 "PR Newswire (US)" - 3/6/2017 4:05:00 PM
ImmunoCellular Therapeutics Provides Update on ICT-107 Phase 3 Glioblastoma Trial and Announces Advances in Stem-to-T-Cell Re... "PR Newswire (US)" - 3/6/2017 6:00:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 2/13/2017 4:06:07 PM
Securities Registration Statement (s-1) "Edgar (US Regulatory)" - 12/28/2016 7:36:52 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 12/14/2016 5:04:41 PM
ImmunoCellular Therapeutics Announces Management Changes "PR Newswire (US)" - 12/14/2016 4:05:00 PM
ImmunoCellular Therapeutics Reports Updated Immune Monitoring Data from ICT-107 Phase 2 Trial in Newly Diagnosed Glioblastoma... "PR Newswire (US)" - 11/21/2016 6:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 11/18/2016 5:17:26 PM
ImmunoCellular Therapeutics Announces One-for-Forty Reverse Stock Split "PR Newswire (US)" - 11/16/2016 6:00:00 AM
Securities Registration: Employee Benefit Plan (s-8) "Edgar (US Regulatory)" - 11/15/2016 6:23:31 AM
biomanbaba  Grandfathered Member Friday, 05/11/12 08:47:45 PM
Re: fm112 post# 984
Post # of 3636 
totally agree with that

SureTrader
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist